---
schema_version: "secwatch.filing_event.v1"
accession: "0001770787-25-000040"
form_type: "8-K"
ticker: "TXG"
cik: "0001770787"
company_name: "10x Genomics, Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:23:44.824418+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# 10x Genomics stockholders re-elect Sri Kosaraju and Shehnaaz Suliman as Class III directors

## Summary
- Kosaraju received 189,313,724 votes for and 7,243,542 against; Suliman 168,973,468 for and 27,595,026 against.
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 215,766,816 votes for.
- Non-binding advisory vote on named executive officer compensation approved with 164,321,765 votes for.
- 108,937,350 shares present or represented by proxy, representing 87.7% of eligible votes, constituting a quorum.

## SEC filing metadata
- accession: 0001770787-25-000040
- form_type: 8-K
- ticker: TXG
- cik: 0001770787
- company_name: 10x Genomics, Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770787/000177078725000040/0001770787-25-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770787/000177078725000040/txg-20250603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001770787-25-000040
- JSON: https://secwatch.observer/filing/0001770787-25-000040.json
- Plain text: https://secwatch.observer/filing/0001770787-25-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.